Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Gout Therapeutics Market Report 2024

Gout Therapeutics Global Market Report 2024 – By Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroid, Diuretics), By Treatment (Xanthine Oxidase Inhibitor, Uricosuria Medication), By Disease Condition (Acute, Chronic), By End-Users (Hospitals, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Gout Therapeutics Global Market Report 2024

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
Customise Your Report
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Gout Therapeutics Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Gout Therapeutics Market Definition And Segments

Gout therapeutics refers to medication that exerts therapeutic effects in treating the disease condition known as gout, or inflammatory arthritis, which causes pain and swelling in joints. Gout therapeutics treat and relieve pain, swelling, and tenderness in joints.

The main types of gout therapeutics are nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and diuretics. Non-steroidal anti-inflammatory drugs (NSAIDs) refer to drugs or medicines used for reducing inflammation, relieving pain, and bringing down a hot temperature. The various treatment includes xanthine oxidase inhibitor, and uricosuria medication used for various disease conditions such as acute, and chronic. These are used by various end-users such as hospitals, specialty clinics, and others.

The gout therapeutics market covered in this report is segmented –

1) By Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroid, Diuretics

2) By Treatment: Xanthine Oxidase Inhibitor, Uricosuria Medication

3) By Disease Condition: Acute, Chronic

4) By End-Users: Hospitals, Specialty Clinics, Other End Users

The gout therapeutics market size has grown rapidly in recent years. It will grow from $2.54 billion in 2023 to $2.86 billion in 2024 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to increased prevalence of gout, changed lifestyle and dietary patterns, high blood pressure and diabetes prevalence, development of xanthine oxidase inhibitors, patient education initiatives.

The gout therapeutics market size is expected to see rapid growth in the next few years. It will grow to $4.41 billion in 2028 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to rising healthcare expenditure, advancements in drug delivery systems, emerging novel therapies, government initiatives for chronic disease management, patient advocacy and support groups. Major trends in the forecast period include innovative drug development, novel drug approvals, personalized medicine approaches, telehealth services for gout management, research in urate-lowering therapies.

Growing Prevalence Of Gout Fuels Expansion In The Gout Therapeutics Market

The rising occurrence of gout is expected to propel the growth of the gout therapeutics market going forward. Gout refers to an inflammatory arthritis condition that causes pain and swelling in joints. Gout therapeutics treat and relieve pain, swelling, and tenderness in joints. As a result, the rising occurrence of gout is expected to boost sales in the gout therapeutics market. For instance, in September 2022, according to reports from the National Health Service, a UK-based publicly funded healthcare system, 250,000 new cases of gout were recorded between 2021 and 2022 in British hospitals, a 20% rise from the previous three years. Therefore, the rising incidence of gout is driving the growth of the gout therapeutics market.

The Rising Prevalence Of Obesity Driving Growth In The Gout Therapeutics Market

The increasing prevalence of obesity is expected to propel the growth of the gout therapeutics market in the coming years. Obesity is a medical disorder defined by an abnormally large buildup of body fat, which can be harmful to one's health. Obesity is thought to be a major risk factor for the development and worsening of gout. Obesity can also worsen the severity and frequency of gout attacks and make them more difficult to manage. For instance, in March 2022, according to the World Health Organization, a Switzerland-based dedicated UN organization in charge of global public health, obesity affects over 1 billion individuals globally, including 340 million adolescents, 39 million children, and 650 million adults. This figure is still rising. According to WHO forecasts, 167 million adults and children will suffer health consequences as a result of being overweight or obese by 2025. Therefore, the increasing prevalence of obesity is driving the gout therapeutics market.

Major companies operating in the gout therapeutics market report are AbbVie Inc., Sanofi-Aventis, AstraZeneca PLC, LG Chem Ltd., GlaxoSmithKline PLC, Takeda Pharmaceuticals Co. Ltd., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Sandoz, Eisai Co. Ltd., Horizon Pharma PLC, Jiangsu HengRui Medicine Co. Ltd., Hikma Pharmaceuticals PLC, Swedish Orphan Biovitrum AB, JW Pharmaceutical Corp, Lannett Company Inc., BioCryst Pharmaceuticals Inc., Selecta Biosciences Inc., Rigel Pharmaceuticals Inc., Avion Pharmaceuticals LLC, Protalix BioTherapeutics Inc., Teijin Pharma Limited, Romeg Therapeutics LLC., CymaBay Therapeutics Inc., GeneScience Pharmaceuticals Co. Ltd., Shanton Pharma

Innovative Treatments Shape The Landscape Of Gout Therapeutics Market

Product innovation is the key trend gaining popularity in the gout therapeutics market. Major companies operating in the gout therapeutics market are developing innovative treatments to sustain their position in the market. For instance, in August 2022, Synlogic Inc., a US-based pharmaceutical company, launched SYNB2081, a new drug candidate for gout treatment. The SYNB2081 is a synthetic biotic designed to lower uric acid. It is the second clinical drug candidate developed through a research collaboration between Synlogic and Ginkgo, a US-based biotech company.

Advancements In Gout Therapeutics Innovative Products Like Corticotropin

Major companies operating in the gout therapeutics market are developing innovative products such as corticotropin to enhance product offerings and gain a competitive advantage. Corticotropin, commonly known as adrenocorticotropic hormone (ACTH), is a hormone made up of peptides secreted by the anterior pituitary gland when subjected to low cortisol levels in the blood. For instance, in January 2022, ANI Pharmaceuticals, Inc., a US-based pharmaceutical company, launched Purified Cortrophin Gel (Repository Corticotropin Injection USP) 80 U/mL. Cortrophin Gel, an adrenocorticotropic hormone (ACTH) commonly known as pure corticotropin, is being commercialized by ANI's newly founded rare illness business unit. Cortrophin Gel is used to treat chronic autoimmune conditions such as acute exacerbations of multiple sclerosis (MS) and gouty arthritis (GA), as well as excess urine protein owing to nephrotic syndrome.

Innovent Biologics And Lg Chem Life Sciences Collaborate On Tigulixostat For Gout Management In China

In December 2022, Innovent Biologics, a China-based biopharmaceutical company, and LG Chem Life Sciences, a US-based pharmaceutical company, entered into a strategic collaboration and license agreement for LG Chem's Tigulixostat for the chronic management of hyperuricemia in patients with gout disease. Through this agreement, Innovent would obtain an exclusive right to develop and commercialize Tigulixostat in China for $95.5 million, including a $10 million upfront payment. LG Chem is eligible for milestones and tiered royalties on net product sales in China. Tigulixostat is a novel xanthine oxidase inhibitor and exhibits therapeutic intervention by targeting the reduction of uric acid in purine metabolism.

North America was the largest region in the gout therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gout therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gout therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gout therapeutics market consists of the sales of allopurinol, benzbromarone, febuxostat, probenecid, and pegloticase drugs. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The gout therapeutics market research report is one of a series of new reports from The Business Research Company that provides gout therapeutics market statistics, including gout therapeutics industry global market size, regional shares, competitors with a gout therapeutics market share, detailed gout therapeutics market segments, market trends, and opportunities, and any further data you may need to thrive in the gout therapeutics industry. This gout therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Gout Therapeutics Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $2.86 billion
Revenue Forecast In 2033 $4.41 billion
Growth Rate CAGR of 11.5% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroid, Diuretics
2) By Treatment: Xanthine Oxidase Inhibitor, Uricosuria Medication
3) By Disease Condition: Acute, Chronic
4) By End-Users: Hospitals, Specialty Clinics, Other End Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled AbbVie Inc.; Sanofi-Aventis; AstraZeneca plc; LG Chem Ltd.; GlaxoSmithKline Plc; Takeda Pharmaceuticals Co. Ltd.; Boehringer Ingelheim International GmbH; Regeneron Pharmaceuticals Inc.; Astellas Pharma Inc.; Sandoz; Eisai Co. Ltd.; Horizon Pharma Plc; Jiangsu HengRui Medicine Co. Ltd.; Hikma Pharmaceuticals plc; Swedish Orphan Biovitrum AB; JW Pharmaceutical Corp; Lannett Company Inc; BioCryst Pharmaceuticals Inc.; Selecta Biosciences Inc.; Rigel Pharmaceuticals Inc.; Avion Pharmaceuticals LLC; Protalix BioTherapeutics Inc.; Teijin Pharma Limited; Romeg Therapeutics LLC.; CymaBay Therapeutics Inc.; GeneScience Pharmaceuticals Co. Ltd.; Shanton Pharma
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Gout Therapeutics Market Characteristics

    3. Gout Therapeutics Market Trends And Strategies

    4. Gout Therapeutics Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Gout Therapeutics Market Size and Growth

    5.1. Global Gout Therapeutics Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Gout Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Gout Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Gout Therapeutics Market Segmentation

    6.1. Global Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

    Corticosteroid

    Diuretics

    6.2. Global Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Xanthine Oxidase Inhibitor

    Uricosuria Medication

    6.3. Global Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Acute

    Chronic

    6.4. Global Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Specialty Clinics

    Other End Users

    7. Gout Therapeutics Market Regional And Country Analysis

    7.1. Global Gout Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Gout Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Gout Therapeutics Market

    8.1. Asia-Pacific Gout Therapeutics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Gout Therapeutics Market

    9.1. China Gout Therapeutics Market Overview

    9.2. China Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Gout Therapeutics Market

    10.1. India Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Gout Therapeutics Market

    11.1. Japan Gout Therapeutics Market Overview

    11.2. Japan Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Gout Therapeutics Market

    12.1. Australia Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Gout Therapeutics Market

    13.1. Indonesia Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Gout Therapeutics Market

    14.1. South Korea Gout Therapeutics Market Overview

    14.2. South Korea Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Gout Therapeutics Market

    15.1. Western Europe Gout Therapeutics Market Overview

    15.2. Western Europe Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Gout Therapeutics Market

    16.1. UK Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Gout Therapeutics Market

    17.1. Germany Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Gout Therapeutics Market

    18.5. France Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Gout Therapeutics Market

    19.9. Italy Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Gout Therapeutics Market

    20.13. Spain Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Gout Therapeutics Market

    21.1. Eastern Europe Gout Therapeutics Market Overview

    21.2. Eastern Europe Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Gout Therapeutics Market

    22.1. Russia Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Gout Therapeutics Market

    23.1. North America Gout Therapeutics Market Overview

    23.2. North America Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Gout Therapeutics Market

    24.1. USA Gout Therapeutics Market Overview

    24.2. USA Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Gout Therapeutics Market

    25.1. Canada Gout Therapeutics Market Overview

    25.2. Canada Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Gout Therapeutics Market

    26.1. South America Gout Therapeutics Market Overview

    26.2. South America Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Gout Therapeutics Market

    27.1. Brazil Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Gout Therapeutics Market

    28.1. Middle East Gout Therapeutics Market Overview

    28.2. Middle East Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Gout Therapeutics Market

    29.1. Africa Gout Therapeutics Market Overview

    29.2. Africa Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Gout Therapeutics Market Competitive Landscape And Company Profiles

    30.1. Gout Therapeutics Market Competitive Landscape

    30.2. Gout Therapeutics Market Company Profiles

    30.2.1. AbbVie Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Sanofi-Aventis

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. AstraZeneca plc

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. LG Chem Ltd.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. GlaxoSmithKline Plc

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Gout Therapeutics Market Other Major And Innovative Companies

    31.1. Takeda Pharmaceuticals Co. Ltd.

    31.2. Boehringer Ingelheim International GmbH

    31.3. Regeneron Pharmaceuticals Inc.

    31.4. Astellas Pharma Inc.

    31.5. Sandoz

    31.6. Eisai Co. Ltd.

    31.7. Horizon Pharma Plc

    31.8. Jiangsu HengRui Medicine Co. Ltd.

    31.9. Hikma Pharmaceuticals plc

    31.10. Swedish Orphan Biovitrum AB

    31.11. JW Pharmaceutical Corp

    31.12. Lannett Company Inc

    31.13. BioCryst Pharmaceuticals Inc.

    31.14. Selecta Biosciences Inc.

    31.15. Rigel Pharmaceuticals Inc.

    32. Global Gout Therapeutics Market Competitive Benchmarking

    33. Global Gout Therapeutics Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Gout Therapeutics Market

    35. Gout Therapeutics Market Future Outlook and Potential Analysis

    35.1 Gout Therapeutics Market In 2028 - Countries Offering Most New Opportunities

    35.2 Gout Therapeutics Market In 2028 - Segments Offering Most New Opportunities

    35.3 Gout Therapeutics Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Gout Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Gout Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: AbbVie Inc. Financial Performance
  • Table 76: Sanofi-Aventis Financial Performance
  • Table 77: AstraZeneca plc Financial Performance
  • Table 78: LG Chem Ltd. Financial Performance
  • Table 79: GlaxoSmithKline Plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Gout Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Gout Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: AbbVie Inc. Financial Performance
  • Figure 76: Sanofi-Aventis Financial Performance
  • Figure 77: AstraZeneca plc Financial Performance
  • Figure 78: LG Chem Ltd. Financial Performance
  • Figure 79: GlaxoSmithKline Plc Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Electricity And Signal Testing Instruments Global Market Report 2024 – By Type (Electricity Testing Instruments, Other Testing and Measuring Instruments, Semiconductor and Signal Testing Instruments), By Services (Calibration Services, Repair Services/ After-sales Services), By Application (Environmental Protection, Rail, Water Affairs, Municipal, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Non-Animal Alternatives Testing Global Market Report 2024 – By Technology (Cell Culture Technology, High Throughput Technology, Molecular Imaging, Omics Technology, Other Technologies), By Method (Cellular Assay, Biochemical Assay, In Silico, Ex-Vivo), By End-User (Pharmaceutical Industry, Cosmetics And Household Products, Diagnostics, Chemicals Industry, Food And Beverage Industry, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Pharmaceutical Sterility Testing Global Market Report 2024 – By Sample (Sterile Drugs, Medical Devices, Biologics and Therapeutics), By Product Type (Instruments, Kits and Reagents, Services), By Type (In- house, Outsourcing), By Test Type (Sterility Testing, Bioburden Testing, Bacterial Endotoxin Testing), By End- User (Compounding Pharmacies, Medical Devices Companies, Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
PCR And Realtime PCR Testing Global Market Report 2024 – By Product (Consumables And Reagents, Instruments, Software And Services), By Technology (Quantitative PCR, Digital PCR), By Application (Clinical Diagnostics, Life Science Research, Industrial Applications, Other Applications), By End-Use (Academic And Research Institutes, Pharmaceutical And Biotechnology, Clinical Diagnostics Labs And Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cloud Services Global Market Report 2024 – By Type (Software as a service (SaaS), Platform as a service (PaaS), Infrastructure as a service (IaaS), Business Process as a service (BPaaS)), By Deployment Model (Public Cloud, Private Cloud, Hybrid Cloud), By Organization Size (Large Enterprises, Small And Medium Enterprises), By Application (Storage, Backup, and Disaster Recovery, Application Development and Testing, Database Management, Business Analytics, Integration and Orchestration, Customer Relationship Management, Other Applications), By End-User Industry (BFSI, Media And Entertainment, IT and Telecommunications, Energy And Utilities, Government And Public Sector, Retail And Consumer Goods, Manufacturing, Other End User Industries) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Application Security Global Market Report 2024 – By Solution (Web Application Security, Mobile Application Security), By Testing Type (Static Application Security Testing, Dynamic Application Security Testing, Interactive Application Security Testing), By End-User (BFSI, IT And Telecommunication, Government And Defense, Healthcare, Retail, Education, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Pyrogen Testing Global Market Report 2024 – By Test Type (LAL Test, In Vitro Test, Rabbit Test), By Product And Service (Assays, Kits, And Reagents, Instruments, Services), By Application (Pharmaceutical And Biologics, Medical Devices, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Antimicrobial Susceptibility Testing Global Market Report 2024 – By Type (Antibacterial Testing, Antifungal Testing, Antiparasitic Testing, Other Types), By Products (Manual Antimicrobial Susceptibility Testing Products, Automated Laboratory Instruments, Consumables), By Application (Diagnostics, Drug Discovery and Development, Epidemiology, Other Applications), By End User (Hospitals And Diagnostic Centers, Pharmaceutical And Biotechnology Companies, Research And Academic Institutes, Clinical Research Organizations (CROs)) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the gout therapeutics market?

Gout therapeutics refers to medication that exerts therapeutic effects in treating the disease condition known as gout, or inflammatory arthritis, which causes pain and swelling in joints. Gout therapeutics treat and relieve pain, swelling, and tenderness in joints. For further insights on the gout therapeutics market, request a sample here

How will the gout therapeutics market drivers and restraints affect the gout therapeutics market dynamics? What forces will shape the gout therapeutics industry going forward?

The gout therapeutics market major growth driver - Growing Prevalence Of Gout Fuels Expansion In The Gout Therapeutics Market. For further insights on the gout therapeutics market, request a sample here

What is the forecast market size or the forecast market value of the gout therapeutics market?

The gout therapeutics market size has grown rapidly in recent years. It will grow from $2.54 billion in 2023 to $2.86 billion in 2024 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to increased prevalence of gout, changed lifestyle and dietary patterns, high blood pressure and diabetes prevalence, development of xanthine oxidase inhibitors, patient education initiatives. The gout therapeutics market size is expected to see rapid growth in the next few years. It will grow to $4.41 billion in 2028 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to rising healthcare expenditure, advancements in drug delivery systems, emerging novel therapies, government initiatives for chronic disease management, patient advocacy and support groups. Major trends in the forecast period include innovative drug development, novel drug approvals, personalized medicine approaches, telehealth services for gout management, research in urate-lowering therapies. For further insights on the gout therapeutics market, request a sample here

How is the gout therapeutics market segmented?

The gout therapeutics market is segmented
1) By Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroid, Diuretics
2) By Treatment: Xanthine Oxidase Inhibitor, Uricosuria Medication
3) By Disease Condition: Acute, Chronic
4) By End-Users: Hospitals, Specialty Clinics, Other End UsersFor further insights on the gout therapeutics market, request a sample here

Which region has the largest share of the gout therapeutics market? What are the other regions covered in the report?

North America was the largest region in the gout therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gout therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the gout therapeutics market, request a sample here.

Who are the major players in the gout therapeutics market?

Major companies operating in the gout therapeutics market report are AbbVie Inc., Sanofi-Aventis, AstraZeneca plc, LG Chem Ltd., GlaxoSmithKline Plc, Takeda Pharmaceuticals Co. Ltd., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Sandoz, Eisai Co. Ltd., Horizon Pharma Plc, Jiangsu HengRui Medicine Co. Ltd., Hikma Pharmaceuticals plc, Swedish Orphan Biovitrum AB, JW Pharmaceutical Corp, Lannett Company Inc, BioCryst Pharmaceuticals Inc., Selecta Biosciences Inc., Rigel Pharmaceuticals Inc., Avion Pharmaceuticals LLC, Protalix BioTherapeutics Inc., Teijin Pharma Limited, Romeg Therapeutics LLC., CymaBay Therapeutics Inc., GeneScience Pharmaceuticals Co. Ltd., Shanton Pharma For further insights on the gout therapeutics market, request a sample here.

What are the key trends in the gout therapeutics market?

Major trend in the gout therapeutics market - Innovative Treatments Shape The Landscape Of Gout Therapeutics Market. For further insights on the gout therapeutics market, request a sample here.

What are the major opportunities in the gout therapeutics market? What are the strategies for the gout therapeutics market?

For detailed insights on the major opportunities and strategies in the gout therapeutics market, request a sample here.

How does the gout therapeutics market relate to the overall economy and other similar markets?

For detailed insights on gout therapeutics market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the gout therapeutics industry?

For detailed insights on the mergers and acquisitions in the gout therapeutics industry, request a sample here.

What are the key dynamics influencing the gout therapeutics market growth? SWOT analysis of the gout therapeutics market.

For detailed insights on the key dynamics influencing the gout therapeutics market growth and SWOT analysis of the gout therapeutics industry, request a sample here.